BIO Port Korea

At a glance

BIO Port Korea filed 30 disclosures in the last 12 months, including 7 insider, 2 earnings, 2 5% holder and 1 buyback. The most recent key filing was on Aug 31.

Revenue for 2025 was ₩70.9B, down 3.4% on 2024. Operating margin was 1.2% against 7.1% a year earlier. Debt was 42% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩43.2B and operating profit of ₩2.3B.

The 2025 annual report lists 112 employees with an average tenure of 4.1 years and average pay of ₩46.6M, #1602 of 1,829 listed companies by average pay. Its 6 directors and auditors were paid ₩154M each on average. It paid no cash dividend for 2025. 김성구 and related parties held 41.09% at year end.

From the 2025 annual report

Staff: 112 (79 men, 33 women), of whom 6 on fixed-term contracts. Total pay for the year: ₩5.2B. Directors and auditors: 6, paid ₩926M in total.

No cash dividend was paid for 2025.

Largest shareholder

김성구 holds 32.54%; with 4 related parties the group holds 41.09% of common shares at year end (from 52.84% at the start of the year).

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary